- Two Health Consortia to Develop a Detailed Feasibility Proposal for Europe’s Next €1-billion Science Projects
- NICE Develops a Medtech Innovation Briefing on Axumin
- Gustave Roussy and Institut Bergonié, Partners for Early Phase Trials and Therapeutic Innovation in Oncology
- Withdrawal of the EU Marketing Authorisation Applications for Cavoley and Efgratin
- FDA Approved Caplacizumab-yhdp
- eUpdate: Hepatocellular Carcinoma Algorithms